AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2017
Dec 15, 2017
30786_dirs_2017-12-14_aed84a49-edd6-457d-8eb7-ac776b89b4d4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-12-14
Reporting Person: TSINGOS CHRISTINE A (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-14 | Bio-Rad A Common Stock | M | 600 | $98.04 | Acquired | 7283.0979 | Direct |
| 2017-12-14 | Bio-Rad A Common Stock | M | 1300 | $107.32 | Acquired | 8583.0979 | Direct |
| 2017-12-14 | Bio-Rad A Common Stock | M | 1280 | $117.00 | Acquired | 9863.0979 | Direct |
| 2017-12-14 | Bio-Rad A Common Stock | M | 800 | $119.54 | Acquired | 10663.0979 | Direct |
| 2017-12-14 | Bio-Rad A Common Stock | M | 1000 | $139.56 | Acquired | 11663.0979 | Direct |
| 2017-12-14 | Bio-Rad A Common Stock | S | 4980 | $249.4016 | Disposed | 6683.0979 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-14 | Non-Qualified Stock Option (right to buy) | $98.04 | M | 600 | Disposed | 2021-11-04 | Bio-Rad A Common Stock (600) | Direct |
| 2017-12-14 | Non-Qualified Stock Option (right to buy) | $107.32 | M | 1300 | Disposed | 2022-09-12 | Bio-Rad A Common Stock (1300) | Direct |
| 2017-12-14 | Non-Qualified Stock Option (right to buy) | $117.00 | M | 1280 | Disposed | 2023-09-11 | Bio-Rad A Common Stock (1280) | Direct |
| 2017-12-14 | Non-Qualified Stock Option (right to buy) | $119.54 | M | 800 | Disposed | 2024-09-10 | Bio-Rad A Common Stock (800) | Direct |
| 2017-12-14 | Non-Qualified Stock Option (right to buy) | $139.56 | M | 1000 | Disposed | 2025-09-11 | Bio-Rad A Common Stock (1000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.15 to $249.54, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The option vested in five equal annual installments beginning November 4, 2012.
F3: The option vested in five equal annual installments beginning September 12, 2013
F4: The option vested in five equal annual installments beginning September 11, 2014.
F5: The option vested in five equal annual installments beginning September 10, 2015.
F6: The option vested in five equal annual installments beginning September 11, 2016.